Cargando…
A semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eye
PURPOSE: Cyclosporine A (Cs) has been used as effective topical therapy for inflammatory dry eye disease since more than a decade. However, due to its lipophilic character, Cs is formulated as emulsions or oily solutions for topical application. This experimental study aimed to test if the use of se...
Autores principales: | Gehlsen, Uta, Braun, Tobias, Notara, Maria, Krösser, Sonja, Steven, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364248/ https://www.ncbi.nlm.nih.gov/pubmed/28091781 http://dx.doi.org/10.1007/s00417-016-3572-y |
Ejemplares similares
-
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease—A Prospective, Multicenter Noninterventional Study
por: Steven, Philipp, et al.
Publicado: (2015) -
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease
por: Steven, Philipp, et al.
Publicado: (2017) -
Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications
por: Tsagogiorgas, Charalambos, et al.
Publicado: (2023) -
Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome
por: Otto, Matthias, et al.
Publicado: (2021) -
A Low Concentration of Tacrolimus/Semifluorinated Alkane (SFA) Eyedrop Suppresses Intraocular Inflammation in Experimental Models of Uveitis
por: De Majumdar, S., et al.
Publicado: (2017)